Cite
HARVARD Citation
Jørgensen, J. et al. (2018). The potential price and access implications of the cost-utility and budget impact methodologies applied by NICE in England and ICER in the US for a novel gene therapy in Parkinson's disease. Journal of market access & health policy. 6 (1), p. . [Online].